News
Xencor to Present Data from the Phase 1 Study of Vudalimab (XmAb®717) and Four Research Programs at the SITC Annual Meeting
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced
Novocure und Roche kooperieren bei klinischen Studien, um Tumortherapiefelder als Teil einer neuartigen Kombination zur Erstbehandlung von metastasierendem Bauchspeicheldrüsenkrebs zu prüfen
Novocure (NASDAQ: NVCR) gab heute den Abschluss eines Vertrags zur Zusammenarbeit mit Roche (SIX: RO. ROG; OTCQX: RHHBY) im Rahmen klinischer Studien bekannt. Ziel ist die Entwicklung von
Premier Inc. to Participate in 2021 Cantor Virtual Global Healthcare Conference on September 30, 2021
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced today that members of its management team are scheduled to participate in a fireside chat at the 2021 Cantor Virtual
Xencor to Present at the 2021 Cantor Virtual Global Healthcare Conference
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced
Geisinger and Acadia Healthcare Hold Groundbreaking Ceremony for New Behavioral Health Center in Moosic
Geisinger and Acadia Healthcare Company today held a groundbreaking ceremony for Geisinger Behavioral Health Center Northeast, a new 96-bed inpatient behavioral health facility. The event occurred
Novocure Announces Clinical Trial Collaboration with Roche to Evaluate Tumor Treating Fields as Part of a Novel Combination for the First-line Treatment of Metastatic Pancreatic Cancer
Novocure (NASDAQ: NVCR) today announced it has entered into a clinical trial collaboration agreement with Roche (SIX: RO. ROG; OTCQX: RHHBY), to develop Tumor Treating Fields (TTFields) together
FDA Grants Breakthrough Device Designation to the NovoTTF-200T™ System for Advanced Liver Cancer
Novocure (NASDAQ: NVCR) today announced the United States Food and Drug Administration (FDA) has granted breakthrough designation to the NovoTTF-200T System, a Tumor Treating Fields (TTFields)
Premier Inc. and 11 Leading Health Systems Invest in Exela Pharma Sciences to Secure and Support U.S.- Based Drug Supply and Manufacturing
Premier Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, and 11 leading health systems acquired a minority stake in Exela Holdings, Inc., the holding company of
Premier Inc. Reduces Board Size and Further Enhances Corporate Governance Profile
Premier, Inc. (NASDAQ: PINC) today announced it has decreased the size of its Board of Directors from 15 to 11, effective August 31, 2021, to further enhance the company’s governance profile. In
Novocure to Participate in the 2021 Wells Fargo Virtual Healthcare Conference
Novocure (NASDAQ: NVCR) announced today that Ashley Cordova, Chief Financial Officer, and Pritesh Shah, Chief Commercial Officer, will participate in the 2021 Wells Fargo Virtual Healthcare
Novocure Appoints Bill Burke as Chief Human Resources Officer
Novocure (NASDAQ: NVCR) today announced that William (Bill) Burke has been promoted to Chief Human Resources Officer, effective September 1, 2021. This appointment reflects the importance of
Premier, Inc. Reports Fiscal-Year 2021 Fourth-Quarter and Full-Year Results and Issues Fiscal-Year 2022 Guidance
Premier, Inc. (NASDAQ: PINC) today reported financial results for the fiscal year 2021 fourth quarter and full year ended June 30, 2021 and issued its fiscal-year 2022 financial guidance.
"We are
ChristianaCare Chooses Premier Inc. to Advance Supply Chain Innovation and Operational Excellence
ChristianaCare, one of the nation’s most dynamic healthcare providers headquartered in Wilmington, Delaware, has selected Premier Inc.’s (NASDAQ: PINC) industry-leading supply chain solutions, to
UnityPoint Health Selects Premier Inc. for Strategic Supply Chain Partnership
UnityPoint Health, a leading network of hospitals, clinics and home care services across the Midwest, has partnered with Premier Inc. (NASDAQ: PINC), a leading technology-driven healthcare
Premier Inc. Brands Technology and Services Platform “PINC AI™”
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today announced that it is branding its comprehensive technology and services platform “PINC AI,” effective immediately.
The
Premier Board of Directors Approves New $250 Million Share Repurchase Program and Increase to Quarterly Cash Dividend
Premier, Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced that its Board of Directors approved a share repurchase program under which the company may repurchase up to $250
Lutheran Health Network of Indiana, LLC and Acadia Healthcare Hold Groundbreaking Ceremony for New Behavioral Health Hospital in Fort Wayne
Lutheran Health Network of Indiana, LLC and Acadia Healthcare Company today held a groundbreaking ceremony for Maple Heights Behavioral Health, a new 120-bed inpatient behavioral health facility in
Xencor Reports Second Quarter 2021 Financial Results
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today reported
Premier Inc. to Participate in KeyBanc Capital Markets Virtual Technology Leadership Forum on August 10, 2021
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced today that members of its management team are scheduled to participate in a fireside chat at the KeyBanc Capital
Acadia Healthcare Reports Second Quarter 2021 Results and Increases 2021 Guidance
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the second quarter ended June 30, 2021.
Second Quarter 2021 Results
The Company reported revenue of $582.2
Xencor to Present at Upcoming Investor Conferences
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced
Novocure Reports Second Quarter 2021 Financial Results and Provides Company Update
Novocure (NASDAQ: NVCR) today reported financial results for the quarter ended June 30, 2021, highlighting commercial strength and strategic investment across clinical, product development and
Xencor to Host Second Quarter 2021 Financial Results Webcast and Conference Call on August 4, 2021
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today
Novocure Announces Recipients of 3rd Annual AACR-Novocure Grants for Tumor Treating Fields Research Program
Novocure (NASDAQ: NVCR) today announced the recipients of the 3rd Annual AACR-Novocure Grants for Tumor Treating Fields Research program. The program represents a joint effort between Novocure and
Premier, Inc. to Report Fiscal 2021 Fourth-Quarter and Full-Year Results and Host Conference Call on August 17, 2021
Premier, Inc. (NASDAQ: PINC) today announced that it will release financial results for its fiscal 2021 fourth quarter and full year on Tuesday, August 17, 2021, at approximately 6:30 a.m. EDT. The